Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

Chief Executive Officer

Chief Financial Officer

See Remarks

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and head and neck cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment o...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-30	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-04-30	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-03-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-02-29	Premium	sold (taxes)	Premium	Premium	Premium	-
2024-02-29	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-02-16	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-15	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-01-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-01-31	Premium	sold (taxes)	Premium	Premium	Premium	-
2023-12-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-12-31	Premium	acquired	Premium	Premium	Premium	-
2023-12-31	Premium	acquired	Premium	Premium	Premium	-
2023-12-31	Premium	sold (taxes)	Premium	Premium	Premium	-
2023-12-26	Premium	bought	Premium	Premium	Premium	-
2023-12-20	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-12-19	Premium	bought	Premium	Premium	Premium	See Remarks
2023-12-19	Premium	bought	Premium	Premium	Premium	-
2023-11-30	Premium	sold (taxes)	Premium	Premium	Premium	-
2023-11-30	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-10-31	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer

BCAB - BioAtla, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for BCAB